PHAT
PHATHOM PHARMA (PHAT)
NASDAQ
$9.04+$0.29 (+3.31%)
Price as of Aug 03, 2026 10:21 AM EDT
  • $697.9M
    Market Cap
  • 4.79%
    1-Year Change
  • Biotechnology
    Industry

Earnings Score

Score: 51
Valuation
PHAT
vs History
vs S&P 500
Profitability
0
Growth
1
Low Earnings Volatility
2

Momentum Score

Score: 18
Valuation
PHAT
vs History
vs S&P 500
3-Month Momentum
-7.02%
12-Month Momentum
23.36%
3-Month Risk Adjusted Momentum
-29.02%
12-Month Risk Adjusted Momentum
40.62%

True Yield

N/A
Valuation
PHAT
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
0.03%
Net Debt Paydown Yield
-0.10%

Financial Health Score

Score: 90
Valuation
PHAT
vs History
vs S&P 500
Ohlson's O-Score
5